Bank Of America Corp Foghorn Therapeutics Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 27,660 shares of FHTX stock, worth $142,172. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,660

Previous 26,907 2.8%

Holding current value

$142,172

Previous $154,000 66.88%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.8 - $9.99 $3,614 - $7,522	753 Added 2.8%	27,660 $257,000
Q2 2024 Aug 14, 2024	BUY	$5.05 - $8.0 $71,603 - $113,432	14,179 Added 111.4%	26,907 $154,000
Q1 2024 May 15, 2024	SELL	$2.82 - $7.94 $46,092 - $129,779	-16,345 Reduced 56.22%	12,728 $85,000
Q4 2023 Feb 14, 2024	BUY	$2.94 - $6.76 $63,357 - $145,678	21,550 Added 286.45%	29,073 $187,000
Q2 2023 Aug 14, 2023	SELL	$5.37 - $8.84 $4,763 - $7,841	-887 Reduced 10.55%	7,523 $52,000
Q1 2023 May 12, 2023	SELL	$4.66 - $8.99 $26,930 - $51,953	-5,779 Reduced 40.73%	8,410 $52,000
Q4 2022 Feb 10, 2023	BUY	$5.44 - $9.46 $27,831 - $48,397	5,116 Added 56.39%	14,189 $90,000
Q3 2022 Nov 14, 2022	SELL	$7.52 - $18.01 $16,265 - $38,955	-2,163 Reduced 19.25%	9,073 $78,000
Q2 2022 Aug 12, 2022	SELL	$8.48 - $16.84 $32,156 - $63,857	-3,792 Reduced 25.23%	11,236 $152,000
Q1 2022 May 16, 2022	SELL	$8.87 - $22.1 $44,216 - $110,168	-4,985 Reduced 24.91%	15,028 $229,000
Q4 2021 Feb 08, 2022	BUY	$10.79 - $22.87 $86,676 - $183,714	8,033 Added 67.05%	20,013 $458,000
Q3 2021 Nov 15, 2021	SELL	$8.33 - $15.02 $2,415 - $4,355	-290 Reduced 2.36%	11,980 $167,000
Q2 2021 Sep 13, 2021	BUY	$9.32 - $13.26 $114,356 - $162,700	12,270 New	12,270 $131,000

Others Institutions Holding FHTX

# of Institutions

Shares Held

33.3M

Call Options Held

8.7K

Put Options Held

2.4K

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $214M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Foghorn Therapeutics Inc. Transaction History